Furthermore, mesenchymal stem cell (MSC)-derived EVs are linked to liver inflammation and NASH progress, and are associated with increased proinflammatory markers (TNF-α, IL-1β, IL-6, and IL-12) [73]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.